Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $446,744 | 250 | 53.5% |
| Consulting Fee | $181,860 | 56 | 21.8% |
| Travel and Lodging | $99,595 | 348 | 11.9% |
| Honoraria | $93,098 | 41 | 11.2% |
| Food and Beverage | $13,202 | 237 | 1.6% |
| Education | $0.83 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alexion Pharmaceuticals, Inc. | $556,183 | 639 | $0 (2024) |
| Kyowa Kirin, Inc. | $135,154 | 130 | $0 (2024) |
| Ultragenyx Pharmaceutical Inc. | $95,298 | 104 | $0 (2023) |
| BioMarin Pharmaceutical Inc. | $16,342 | 31 | $0 (2023) |
| Ascendis Pharma Inc | $13,125 | 5 | $0 (2023) |
| Ipsen Biopharmaceuticals, Inc | $11,019 | 7 | $0 (2024) |
| Horizon Therapeutics plc | $5,423 | 10 | $0 (2022) |
| Regeneron Pharmaceuticals, Inc. | $1,733 | 2 | $0 (2024) |
| Amgen Inc. | $177.77 | 2 | $0 (2019) |
| Shire North American Group Inc | $25.39 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $179,152 | 182 | Alexion Pharmaceuticals, Inc. ($103,515) |
| 2023 | $140,178 | 135 | Alexion Pharmaceuticals, Inc. ($69,597) |
| 2022 | $94,041 | 92 | Alexion Pharmaceuticals, Inc. ($41,077) |
| 2021 | $80,938 | 89 | Alexion Pharmaceuticals, Inc. ($50,004) |
| 2020 | $75,117 | 68 | Alexion Pharmaceuticals, Inc. ($54,008) |
| 2019 | $58,272 | 91 | Alexion Pharmaceuticals, Inc. ($43,834) |
| 2018 | $96,673 | 145 | Alexion Pharmaceuticals, Inc. ($87,079) |
| 2017 | $110,128 | 131 | Alexion Pharmaceuticals, Inc. ($107,069) |
All Payment Transactions
933 individual payment records from CMS Open Payments — Page 1 of 38
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Food and Beverage | In-kind items and services | $26.30 | General |
| Category: Rare Disease | ||||||
| 11/14/2024 | Alexion Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,230.00 | General |
| 11/07/2024 | Alexion Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,230.00 | General |
| 10/30/2024 | Alexion Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $820.00 | General |
| 10/18/2024 | Alexion Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,280.00 | General |
| 10/18/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Travel and Lodging | Cash or cash equivalent | $56.00 | General |
| Category: Rare Disease | ||||||
| 10/18/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Food and Beverage | Cash or cash equivalent | $27.06 | General |
| Category: Rare Disease | ||||||
| 10/17/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,280.00 | General |
| Category: Rare Disease | ||||||
| 10/17/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,230.00 | General |
| Category: Rare Disease | ||||||
| 10/17/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Travel and Lodging | In-kind items and services | $761.95 | General |
| Category: Rare Disease | ||||||
| 10/17/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Travel and Lodging | In-kind items and services | $736.75 | General |
| Category: Rare Disease | ||||||
| 10/17/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Travel and Lodging | Cash or cash equivalent | $137.18 | General |
| Category: Rare Disease | ||||||
| 10/17/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Food and Beverage | In-kind items and services | $119.26 | General |
| Category: Rare Disease | ||||||
| 10/17/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Travel and Lodging | Cash or cash equivalent | $73.63 | General |
| Category: Rare Disease | ||||||
| 10/17/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Travel and Lodging | Cash or cash equivalent | $44.92 | General |
| Category: Rare Disease | ||||||
| 10/17/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Food and Beverage | Cash or cash equivalent | $41.24 | General |
| Category: Rare Disease | ||||||
| 10/17/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Food and Beverage | In-kind items and services | $24.90 | General |
| Category: Rare Disease | ||||||
| 10/17/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Food and Beverage | Cash or cash equivalent | $19.77 | General |
| Category: Rare Disease | ||||||
| 10/16/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,230.00 | General |
| Category: Rare Disease | ||||||
| 10/15/2024 | Kyowa Kirin, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $880.00 | General |
| 10/09/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,230.00 | General |
| Category: Rare Disease | ||||||
| 10/08/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,230.00 | General |
| Category: Rare Disease | ||||||
| 10/08/2024 | Alexion Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,230.00 | General |
| 10/04/2024 | Kyowa Kirin, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,225.00 | General |
| 10/03/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,280.00 | General |
| Category: Rare Disease | ||||||
About Dr. Eric Rush, M.D
Dr. Eric Rush, M.D is a Clinical Genetics (M.D.) healthcare provider based in Kansas City, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/29/2007. The National Provider Identifier (NPI) number assigned to this provider is 1952420705.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Rush, M.D has received a total of $834,499 in payments from pharmaceutical and medical device companies, with $179,152 received in 2024. These payments were reported across 933 transactions from 12 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($446,744).
Practice Information
- Specialty Clinical Genetics (M.D.)
- Other Specialties Clinical Genetics (M.D.)
- Location Kansas City, MO
- Active Since 03/29/2007
- Last Updated 07/21/2022
- Taxonomy Code 207SG0201X
- Entity Type Individual
- NPI Number 1952420705
Products in Payments
- Strensiq (Drug) $218,468
- STRENSIQ (Biological) $108,418
- Crysvita (Drug) $106,338
- Cryvista (Drug) $19,984
- SOLIRIS (Drug) $10,266
- CRYSVITA (Drug) $9,003
- Vimizim (Biological) $8,349
- RAVICTI (Drug) $5,423
- Kanuma (Drug) $4,205
- Brineura (Biological) $1,500
- Sohonos (Drug) $1,429
- Bylvay (Drug) $1,350
- Palynziq (Drug) $125.00
- Prolia (Biological) $90.34
- NATPARA (Drug) $25.39
- LYNPARZA (Biological) $18.46
- (820) Cholbam (Drug) $0.83
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Clinical Genetics (M.D.) Doctors in Kansas City
Mr. Jeffrey Weitzel, Md, MD
Clinical Genetics (M.D.) — Payments: $117,303
Dr. Merlin Butler, M.d., Ph.d, M.D., PH.D
Clinical Genetics (M.D.) — Payments: $10,817
Angela Lee, Md, MD
Clinical Genetics (M.D.) — Payments: $490.19
Dr. Laurie Smith, Md, Phd, MD, PHD
Clinical Genetics (M.D.) — Payments: $476.10
Dr. Shivarajan Manickavasagam Amudhavalli, M.b.b.s, M.B.B.S
Clinical Genetics (M.D.) — Payments: $310.41
Bryce Heese, Md, MD
Clinical Genetics (M.D.) — Payments: $169.14